Morgan Stanley analyst Dara Mohsenian reduced Clorox’s price target to $125 from $137 and maintained an Equal Weight rating due to weak fiscal Q1 results and lower full-year EPS guidance. The company reported a 19% revenue drop to $1.43 billion in Q1 2026, with organic sales falling 17% and gross margin slipping to 41.7%. CEO Linda Rendle highlighted the new ERP system rollout, expecting organic sales to decline in the first half and rise in the second half. CFO Luc Bellet projected subdued growth in the US retail category. Clorox offers cleaning, disinfecting, and other consumer products.

Read more at Yahoo Finance: Morgan Stanley Trims Clorox (CLX) Price Target After Soft Q1 Performance